Gilead Sciences (GB:0QYQ)

Gilead Sciences (0QYQ) Financial Statements


Gilead Sciences Financial Overview

Gilead Sciences's market cap is currently ―. The company's EPS TTM is $4.663; its P/E ratio is 16.75; and it has a dividend yield of 3.82%. Gilead Sciences is scheduled to report earnings on February 6, 2024, and the estimated EPS forecast is $1.78. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 7.05B$ 6.56B$ 6.31B$ 7.39B$ 7.04B
Gross Profit$ 5.49B$ 5.16B$ 4.95B$ 5.99B$ 5.65B
EBIT$ 2.55B$ 1.82B$ 1.53B$ 2.26B$ 2.66B
EBITDA$ 3.23B$ 2.50B$ 2.17B$ 2.79B$ 3.19B
Net Income Common Stockholders$ 2.18B$ 1.04B$ 1.01B$ 1.64B$ 1.79B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.16B$ 6.67B$ 5.87B$ 6.38B$ 5.66B
Total Assets$ 62.37B$ 62.34B$ 61.88B$ 63.17B$ 62.56B
Total Debt$ 24.98B$ 25.25B$ 25.24B$ 25.23B$ 25.22B
Net Debt$ 23.82B$ 18.58B$ 19.37B$ 18.84B$ 19.56B
Total Liabilities$ 40.13B$ 41.24B$ 40.94B$ 41.96B$ 41.50B
Stockholders Equity$ 22.31B$ 21.16B$ 21.00B$ 21.24B$ 21.08B
Cash Flow-
Free Cash Flow$ 2.35B$ 1.48B$ 1.64B$ 2.39B$ 2.71B
Operating Cash Flow$ 2.47B$ 1.62B$ 1.75B$ 2.57B$ 2.86B
Investing Cash Flow$ -229.00M$ -483.00M$ -826.00M$ -375.00M$ -713.00M
Financing Cash Flow$ -2.24B$ -383.00M$ -1.41B$ -1.55B$ -2.12B
Currency in USD

Gilead Sciences Earnings and Revenue History

Gilead Sciences Debt to Assets

Gilead Sciences Cash Flow

Gilead Sciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis